The FTC's probe into pharmacy benefit managers for anti-competitive practices has sparked legal actions from state Attorneys General. While PBMs claim to control costs, investigations reveal they steer patients to higher-priced drugs. Transparency and understanding PBM practices are crucial in the healthcare market.